Ginkgo Bioworks Holdings Stock Investor Sentiment

DNA Stock  USD 8.26  0.31  3.90%   
About 60% of Ginkgo Bioworks' investor base is looking to short. The analysis of the overall investor sentiment regarding Ginkgo Bioworks Holdings suggests that many traders are alarmed. The current market sentiment, together with Ginkgo Bioworks' historical and current headlines, can help investors time the market. In addition, many technical investors use Ginkgo Bioworks Holdings stock news signals to limit their universe of possible portfolio assets.

Panic Vs Confidence

40

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Ginkgo Bioworks' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Ginkgo Bioworks Holdings.

Ginkgo Historical Sentiment

Although Ginkgo Bioworks' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Ginkgo, such as negative comments on social media and news outlets, may cause fear in the market and push Ginkgo Bioworks' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Ginkgo.
  

Ginkgo Bioworks Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Ginkgo Bioworks can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Ginkgo Bioworks Holdings Historical Investor Sentiment

Investor biases related to Ginkgo Bioworks' public news can be used to forecast risks associated with an investment in Ginkgo. The trend in average sentiment can be used to explain how an investor holding Ginkgo can time the market purely based on public headlines and social activities around Ginkgo Bioworks Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ginkgo Bioworks' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ginkgo Bioworks and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Ginkgo Bioworks news discussions. The higher the estimate score, the more favorable the investor's outlook on Ginkgo Bioworks.
over two weeks ago at nypost.com         
Your sweet tooth may be genetic and your DNA could be pushing you to eat more, says new study
news
over two weeks ago at investing.com         
Earnings call Ginkgo Bioworks Navigates Cost Cuts Amid Revenue Shift
Investing News at Macroaxis
over two weeks ago at prnewswire.com         
DNA Sequencing Market to Grow by USD 17.34 Billion , Driven by Rising NGS Adoption, AI-Powered Repor...
prnewswire News
over two weeks ago at globenewswire.com         
Myriad Genetics Expands Access to At-Home Early Fetal Sex DNA Testwith Retail Launch
Macroaxis News: globenewswire.com
over two weeks ago at bizjournals.com         
Ginkgo nixes move to South Boston lab, will exit Cambridge sites
bizjournals News
over two weeks ago at insidermonkey.com         
Ginkgo Bioworks Holdings, Inc. Q3 2024 Earnings Call Transcript
insidermonkey News
over two weeks ago at prnewswire.com         
Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing
prnewswire News
over two weeks ago at gurufocus.com         
Ginkgo Bioworks Q3 2024 Earnings Revenue Surges to 89 Million, Driven by Deferred Revenue Release
Gurufocus Stories at Macroaxis
over two weeks ago at seekingalpha.com         
Ginkgo Bioworks Holdings GAAP EPS of -1.08 beats by 2.24, revenue of 89.05M beats by 44.06M
seekingalpha News
over two weeks ago at seekingalpha.com         
Ginkgo Bioworks completes first milestone in Merck collaboration
seekingalpha News
over two weeks ago at prnewswire.com         
Ginkgo Bioworks Reports Third Quarter 2024 Financial Results
prnewswire News
over two weeks ago at businesswire.com         
Ansa Biotechnologies Sets New Standard in Long, Complex DNA
businesswire News
over two weeks ago at businesswire.com         
Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer...
businesswire News
over two weeks ago at medcitynews.com         
Driving Genetic Testing Adoption and Improved Patient Care through Health Data Intelligence
news
over two weeks ago at scmp.com         
Scholars debunk myth of Roman settlement in China with DNA tests, tourists undeterred
news
Far too much social signal, news, headlines, and media speculation about Ginkgo Bioworks that are available to investors today. That information is available publicly through Ginkgo media outlets and privately through word of mouth or via Ginkgo internal channels. However, regardless of the origin, that massive amount of Ginkgo data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ginkgo Bioworks news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ginkgo Bioworks relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ginkgo Bioworks' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ginkgo Bioworks alpha.

Ginkgo Bioworks Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Metaverse Dualchain Network Architecture Hits Market Cap of 120,824.35
10/11/2024
2
Metaverse Dualchain Network Architecture Hits 24 Hour Trading Volume of 1,392.54
10/25/2024
3
Your Food is Failing You An At-Home DNA Test Can Show You Whats Missing
11/04/2024
4
Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer Care
11/11/2024
5
Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing
11/12/2024
6
Ginkgo Bioworks Holdings Inc Q3 2024 Earnings Call Highlights Strategic Restructuring ...
11/13/2024
7
Smoking pot can increase cancer risk, speed up aging and harm your future children
11/14/2024
8
DNA Sequencing Research Report 2024 - Global Forecast to 2031 21.3 Billion Market to Benefit from Growing Use in Clinical Applications and Extensive Genomic Pro...
11/19/2024
9
Renew Biotechnologies Wins BioTech Breakthrough Award for DNA Sequencing Innovation of the Year
11/21/2024
10
Acquisition by Sloan Harry of 4222 shares of Ginkgo Bioworks subject to Rule 16b-3
11/22/2024
11
DNA links suspect to 1979 California cold case killing decades after he passed lie detector test
11/26/2024

Complementary Tools for Ginkgo Stock analysis

When running Ginkgo Bioworks' price analysis, check to measure Ginkgo Bioworks' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ginkgo Bioworks is operating at the current time. Most of Ginkgo Bioworks' value examination focuses on studying past and present price action to predict the probability of Ginkgo Bioworks' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ginkgo Bioworks' price. Additionally, you may evaluate how the addition of Ginkgo Bioworks to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
CEOs Directory
Screen CEOs from public companies around the world
Money Managers
Screen money managers from public funds and ETFs managed around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope